Drugs / Febuxostat 40MG Tablets
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT06603142 Comparator | Apr 2024 → Apr 2026 overdue | gout | Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Febuxostat 40MG Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06603142 ↗ |